Cingulate (CING) Research & Development (2021 - 2026)
Cingulate (CING) reported Research & Development of $1.49 million for Q2 2026, down 45.0% from $2.7 million a year earlier.
Powered by 
Analysis
Cingulate (CING) Research & Development (2021 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Cingulate's Research & Development came in at $9.04 million, down 15.4% year-over-year; for FY2025, it was $9.77 million, up 3.5% from FY2024.
- Research & Development has a four-year compound annual growth rate of 3.8% (FY2021 to FY2025).
- By year, Research & Development came in at $9.45 million in FY2024 (-39.0%), $15.49 million in FY2023 (+72.2%), $9 million in FY2022 (+7.0%) and $8.41 million in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly Research & Development since Q3 2024.
- Year over year, Research & Development gained in three of the last seven quarters, with an average decline of 1.4%.
- The high point for year-over-year Research & Development in five years was Q1 2022 (growth of 391.1%); the low point was Q3 2024 (a decline of 63.6%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.82 Bn | 1,105.41 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 617.41 Bn | 535.94 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 501.29 Bn | 474.40 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 368.15 Bn | 322.53 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 297.07 Bn | 261.06 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 260.90 Bn | 234.58 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 236.34 Bn | 191.74 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 191.00 Bn | 165.20 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 169.72 Bn | 116.36 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Cingulate | 61.71 Mn | 6.72 Mn | - | 1.49 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.49 Mn |
| Dec 31, 2025 | 2.00 Mn |
| Sep 30, 2025 | 2.85 Mn |
| Jun 30, 2025 | 2.70 Mn |
| Mar 31, 2025 | 2.22 Mn |
| Dec 31, 2024 | 4.33 Mn |
| Sep 30, 2024 | 1.43 Mn |
| Jun 30, 2024 | 1.88 Mn |
| Mar 31, 2024 | 1.81 Mn |
| Dec 31, 2023 | 4.98 Mn |
| Sep 30, 2023 | 3.92 Mn |
| Jun 30, 2023 | 4.46 Mn |
| Mar 31, 2023 | 2.13 Mn |
| Dec 31, 2022 | 1.93 Mn |
| Sep 30, 2022 | 2.12 Mn |
| Jun 30, 2022 | 2.18 Mn |
| Mar 31, 2022 | 2.76 Mn |
| Dec 31, 2021 | 1.26 Mn |
| Sep 30, 2021 | 5.79 Mn |
| Jun 30, 2021 | 793,587.00 |
API Access
Cingulate Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=CING&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "CING", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=CING&period=max&api_key=YOUR_API_KEY");
const data = await res.json();